Co-morbidities

Harriette Van Spall, Mark Petrie

Debar Rasoul , Ashwin Ajay , Alend Abdullah , et al

Read time: 18m
EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Listen time: 1h 3m 40s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer

Watch time: 1h 5m 20s

Ileana L Piña, Gianluigi Savarese, , et al

Ileana L Piña, Gianluigi Savarese, , et al

CardioNerds @AHA23: An Extended Duration Short-Interfering RNA Targeting Lp(a)

Steven E Nissen, Maryam Barkhordarian

Watch time: 9m 14s
HFA 23: DAPA-RESIST: Dapagliflozin Vs Metolazone in Diuretic-Resistant HF

Ross Campbell

Watch time: 3m 56s
HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Robert Mentz, Harriette Van Spall

Watch time: 5m 48s

Fausto J Pinto, John Spertus et al

View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 33m 36s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Christiane Angermann, Javed Butler, Clyde W Yancy, et al

Watch time: 1h 4m (6 videos)

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)

Shelley Zieroth, Martin R Cowie, Javed Butler, et al

Watch time: 53m 14s (5 videos)

Andrew JS Coats, Stefan Anker

Watch time: 23h 16m 49s (126 videos)

Shelley Zieroth et al

Watch time: 20m 16s (3 videos)

Fausto J Pinto, John Spertus et al

Shelley Zieroth, Andrew Frankel, James Burton, et al

Watch time: 1h 34m 52s

Silvio Inzucchi, Andrew JS Coats, Richard Hobbs, et al

Watch time: 1h 10m 25s

Andrew JS Coats

Watch time: 5m 51s (1 video)

Su Down, Jas Gill, Andrew Frankel, et al

Watch time: 56m 1s (5 videos)

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Watch time: 53m 45s

Debar Rasoul , Ashwin Ajay , Alend Abdullah , et al

Read time: 18m

About

Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.

Media

HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Robert Mentz, Harriette Van Spall

Watch time: 5m 48s

Fausto J Pinto, John Spertus et al

ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Silvio Inzucchi, Andrew JS Coats, Richard Hobbs, et al

Watch time: 1h 10m 25s

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Shelley Zieroth, Andrew Frankel, James Burton, et al

Watch time: 1h 34m 52s

Christiane Angermann, Javed Butler, Clyde W Yancy, et al

Watch time: 1h 4m (6 videos)

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong, et al

Watch time: 53m 45s

Andrew JS Coats, Stefan Anker

Watch time: 23h 16m 49s (126 videos)
Watch Now

Carlos Juanatey

Watch time: 9m 50s
Watch Now

Stylianos Tzeis

Watch time: 11m 57s

Media

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Shelley Zieroth, Andrew Frankel, James Burton, et al

Watch time: 1h 34m 52s

Ileana L Piña, Gianluigi Savarese, , et al

Ileana L Piña, Gianluigi Savarese, , et al

ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s
Radcliffe & CardioNerds @AHA22: EMPA-Kidney: Empagliflozin & CV Outcomes in Patients with Chronic Kidney Disease

Kate Wilcox, David Preiss

Watch time: 18m 1s
HF 22: SCD Risk Protection for Newly Diagnosed HF Patients

José González-Costello

Watch time: 2m 16s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer

Watch time: 1h 5m 20s

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)

Su Down, Jas Gill, Andrew Frankel, et al

Watch time: 56m 1s (5 videos)

Fausto J Pinto, John Spertus et al

Articles

Alcohol and Heart Failure

Debar Rasoul

,

Ashwin Ajay

,

Alend Abdullah

,

Jean Mathew

,

Benjamin Lee Wei En

,

Knievel Mashida

,

Rajiv Sankaranarayanan

,

Published:

26 December 2023

Citation:

European Cardiology Review 2023;18:e65.

DOI:

https://doi.org/10.15420/ecr.2023.12
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 3317
  • Downloads: Downloads 171
  • Citations: 2
  • Read time: 18m

Cardio-oncology in 2022

Rebecca Dobson

,

Published:

16 February 2023

Citation:

European Cardiology Review 2023;18:e04.

DOI:

https://doi.org/10.15420/ecr.2022.45
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1072
  • Downloads: Downloads 92
  • Read time: 4m

Ranolazine to Improve Diastolic Performance

Desak Ketut Sekar Cempaka Putri

,

Andrianto Andrianto

,

Makhyan Jibril Al-Farabi

,

Pandit Bagus Tri Saputra

,

Ricardo Adrian Nugraha

,

Published:

21 January 2023

Citation:

European Cardiology Review 2023;18:e02.

DOI:

https://doi.org/10.15420/ecr.2022.10
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1862
  • Downloads: Downloads 131
  • Citations: 1
  • Read time: 10m

Transvenous Phrenic Nerve Stimulation - A Novel Therapy for Central Sleep Apnoea in Heart Failure

Sitaramesh Emani

,

William T Abraham

,

Citation:

European Cardiology 2012;8(1):44-7

DOI:

https://doi.org/10.15420/ecr.2012.8.1.44
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 422
  • Downloads: Downloads 3